CMT2A is an axonal non-demyelinating peripheral neuropathy, manifesting in the first or second decade of life, with an estimated incidence of 1–3:100,000 [141,153], and is considered one of the most four frequent neuropathies, and the most frequent CMT2 (axonal neuropathy) [154]. This evidence concerns the gene MFN2 and axonal neuropathy.